Japan Medical Dynamic Marketing, INC. (TYO:7600)
Japan · Delayed Price · Currency is JPY 929.00
+26.00 (2.88%)
Aug 6, 2026, 11:30 AM JST
TYO:7600 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 23,322 | 23,917 | 25,114 | 23,177 | 21,307 | 19,193 | |
Revenue Growth | -6.64% | -4.77% | 8.36% | 8.78% | 11.01% | 14.67% |
Cost of Revenue | 9,898 | 9,775 | 9,468 | 8,415 | 7,316 | 6,204 |
Gross Profit | 13,423 | 14,142 | 15,646 | 14,762 | 13,991 | 12,989 |
Selling, General & Admin | 11,179 | 11,301 | 11,530 | 10,631 | 9,809 | 8,443 |
Research & Development | 917.95 | 864 | 959 | 874 | 662 | 485 |
Other Operating Expenses | - | - | 162 | 148 | 146 | 158 |
Operating Expenses | 13,525 | 13,567 | 14,090 | 13,015 | 11,967 | 10,327 |
Operating Income | -101.45 | 575 | 1,556 | 1,747 | 2,024 | 2,662 |
Interest Expense | -216.05 | -200 | -75 | -32 | -18 | -30 |
Earnings From Equity Investments | -59.32 | -58 | -56 | -65 | -63 | -12 |
Currency Exchange Gain (Loss) | 283.01 | 230 | 63 | 190 | 100 | -35 |
Other Non Operating Income (Expenses) | -19.41 | -15 | 1 | 1 | - | 6 |
EBT Excluding Unusual Items | -113.22 | 532 | 1,489 | 1,841 | 2,043 | 2,591 |
Gain (Loss) on Sale of Investments | - | - | - | -72 | - | - |
Asset Writedown | -31.9 | -32 | -52 | -48 | -56 | -87 |
Legal Settlements | - | - | -1,555 | -75 | - | - |
Other Unusual Items | -8 | -8 | -224 | -11 | -218 | 245 |
Pretax Income | -153.12 | 492 | -342 | 1,635 | 1,769 | 2,749 |
Income Tax Expense | 63.57 | 218 | 126 | 331 | 334 | 608 |
Earnings From Continuing Operations | -216.68 | 274 | -468 | 1,304 | 1,435 | 2,141 |
Minority Interest in Earnings | -3.19 | -11 | 7 | -33 | -12 | -6 |
Net Income | -219.88 | 263 | -461 | 1,271 | 1,423 | 2,135 |
Net Income to Common | -219.88 | 263 | -461 | 1,271 | 1,423 | 2,135 |
Net Income Growth | - | - | - | -10.68% | -33.35% | 28.31% |
Shares Outstanding (Basic) | 26 | 26 | 26 | 26 | 26 | 26 |
Shares Outstanding (Diluted) | 26 | 26 | 26 | 26 | 26 | 26 |
Shares Change | 0.06% | 0.05% | 0.05% | -0.11% | -0.12% | -0.00% |
EPS (Basic) | -8.34 | 9.98 | -17.51 | 48.29 | 54.00 | 80.92 |
EPS (Diluted) | -8.34 | 9.98 | -17.51 | 48.29 | 54.00 | 80.92 |
EPS Growth | - | - | - | -10.58% | -33.27% | 28.31% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -1,756 | -505 | 321 | 964 | 1,572 |
Free Cash Flow Per Share | - | -66.65 | -19.18 | 12.20 | 36.58 | 59.58 |
Dividend Per Share | 17.000 | 17.000 | 15.000 | 14.000 | 13.000 | 12.000 |
Dividend Growth | 13.33% | 13.33% | 7.14% | 7.69% | 8.33% | 9.09% |
Gross Margin | 57.56% | 59.13% | 62.30% | 63.69% | 65.66% | 67.68% |
Operating Margin | -0.43% | 2.40% | 6.20% | 7.54% | 9.50% | 13.87% |
Profit Margin | -0.94% | 1.10% | -1.84% | 5.48% | 6.68% | 11.12% |
Free Cash Flow Margin | - | -7.34% | -2.01% | 1.39% | 4.52% | 8.19% |
EBITDA | 1,497 | 2,188 | 3,227 | 3,342 | 3,573 | 4,082 |
EBITDA Margin | 6.42% | 9.15% | 12.85% | 14.42% | 16.77% | 21.27% |
D&A For EBITDA | 1,599 | 1,613 | 1,671 | 1,595 | 1,549 | 1,420 |
EBIT | -101.45 | 575 | 1,556 | 1,747 | 2,024 | 2,662 |
EBIT Margin | -0.43% | 2.40% | 6.20% | 7.54% | 9.50% | 13.87% |
Effective Tax Rate | - | 44.31% | - | 20.24% | 18.88% | 22.12% |
Advertising Expenses | - | - | 197 | 295 | 279 | 220 |